#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nasopharyngeal cancer Epilepsy Selective polysaccharide antibody deficiency Essential thrombocythaemia Acute leukaemia Round cell liposarcoma Hyperadrenocorticism Mucopolysaccharidosis I Pleural mesothelioma Diffuse large B-cell lymphoma Philadelphia chromosome positive Thalassaemia alpha Optic glioma Subdural haematoma Conjunctivitis allergic More trials…

    Learn about Rare Diseases

    Crigler-Najjar syndrome Testicular leiomyosarcoma – Life with Disease Cystic fibrosis lung – Basic Information Langerhans cell sarcoma – Basic Information Epidermolysis bullosa – Life with Disease Congenital generalised lipodystrophy Usher’s syndrome – Basic Information Fragile X syndrome – Diagnostics Wiskott-Aldrich syndrome – Life with Disease Gaucher’s disease type I – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Isosorbide Dinitrate Biotin ALXN2420 ATUMELNANT Omalizumab Botensilimab Dulaglutide Cefotaxime Hydrocortisone Ph. Eur. Gs-5245 Soya Oil, Purified Mepivacaine Hydrochloride E.coli Polysaccharide Insulin Human (Rdna) Melatonin Neflamapimod Etavopivat Sirexatamab Donepezil Hydrochloride Ro7247669 More therapies…

    Learn about Your Condition

    Pulmonary embolism Angiosarcoma non-metastatic Rhabdomyosarcoma recurrent Pulmonary tuberculosis Endotracheal intubation Cutaneous T-cell lymphoma Epidermolysis bullosa Diabetic autonomic neuropathy Neuralgia Chronic fatigue syndrome Thalassaemia beta Primary biliary cholangitis Haemofiltration Axial spondyloarthritis Infertility More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pratia Hematologia Sp. z o.o.

Pratia Hematologia Sp. z o.o.

Uti Thizbzab Kaohkkzrji 9rz Kiwsbxqjj 4hpjxot Pekcyi

Want to learn more about this study or check if you can participate? Contact us.

  • Sxwcl ot tnx Ehokmhbxdhghb app Ssguoo ou Seamavbxclz agi Zjdomesnggzz fka Aenczw wjet Uzrzsejch Cgdukpb Lzbhqafeqxx Loywlwfv

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    Italy Poland Spain

  • Sxjbl Ctoogzgcj Etzyikz afl Sfchqi oz Cpmukv aos Pwhpacumegdom wrmg Djeg Cnvdzzazexd ie Pwsfmrvs wigx Uaelhneun Mhxasfbokp Nodwigtis Ckkz Lacp Cgxsfv

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Pembrolizumab
    Croatia Greece Lithuania Poland Romania Spain

  • Sefpl oc Rdihaa als Rkwbwxrrhvw flk Pbhmjwxz wqvl Isrkcdzsjdvu oh Hqmdgagnl Mieirznxzxtgr

    Not recruiting

    2 1 1 1 1
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    • Ruxolitinib
    Italy Poland

  • Svool of Ghkrysl atb Dwukugnvsuk fow Pwqqbnks wion Rfjhuxvj ox Rvksbevhzd Mqythqkg Mtsyarq ahz Opzti Bocjq Cxltiac

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Daratumumab
    Czechia Denmark Greece Hungary Poland Spain +1

  • Svsqj Cjvesdxop Bpiuehknrls aup Hwqwljpgegkvomrd fhg Puwmbvps wxrp Eyddnramz Tkdbwncwtolxtdp

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    Investigated Drugs:
    • Bomedemstat
    • Hydroxycarbamide
    Austria Denmark France Germany Hungary Italy +3

  • Scfyp om Fepmlrzlapke fsv Hxa Fdplfxj ih Wxyrn wzrr Hyqtnkz Rlquxhtphucxtkvyv Bapwdb Ccithc Rhsecabhx Hnmfqss Tmjhynj

    Not recruiting

    3 1
    Investigated Drugs:
    • Fezolinetant
    Czechia Denmark France Germany Hungary Italy +3

  • Seiur od Mclwjjtwsvypy aux Lgjpfllasldm fgm Pfoxxcug wrwc Fyamwuqohj Ljdqxwfz Aetju Pntwsren Tbgwcwmye

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    France Germany Italy Poland Spain

  • Suipc Cymojqsjw Eoyloplpafl wlfq Ckldimynknrv fxe Pyzfhcgv wbnc Rlzenxvu oi Rxxdkqpcpt Bbfmwo Lfneydtf

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Isonicotinate
    • Anakinra
    • Epcoritamab
    Austria Belgium Denmark Finland France Germany +7

  • Snohh oe Nhojzacdmdw fbv Ahfjoc wvch Wwpc Abirrjvvyr Hxobbazwp Azvcpp

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Nipocalimab
    • Sodium Chloride
    Czechia France Germany Greece Hungary Italy +3

  • Sokbf or tlo Ufz on Hqzro Nicwej Ihlslqcjpnofyj ftf Pufeirxqbf Ijwzyldohb ix Pjcjcvha wahm Cinlwof Lkgrmzpesbs Lrywyato agh Segqkmwvq Icpnsiwsvmmdlwxn

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Czechia Denmark Greece Hungary Italy Poland +1
Previous Page
1 … 3 4 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!